Search

Overview Idiopathic hypersomnia is a condition that causes people to be very sleepy during the day even after a full night of sleep. People with the condition have trouble waking [...]

Þµ Data From Narcolepsy Type 2 Cohort of ALKS 2680 Phase 1b Study to be Presented in Oral Presentation Þµ Þµ Data From Idiopathic Hypersomnia Cohort of ALKS 2680 Phase [...]

2024 SEP 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on narcolepsy is the subject of a new report. According to [...]

KP1077 was well tolerated and showed meaningful clinical improvements in patient-reported assessments of daytime sleepiness, sleep inertia, and brain fog Additional data presented on pharmacokinetics of morning and nighttime doses [...]

2024 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Experienced non-profit leader and author Jason Fisher appointed to first-ever professional staff role for the Foundation SAN JOSE, Calif., May 30, 2024 /PRNewswire/ --The Kleine-Levin Syndrome Foundation today announced the [...]

CELEBRATION: Zevra Therapeutics, Inc. announces top-line data from its placebo-controlled, double-blind Phase 2 clinical trial evaluating the safety and tolerability of KP1077 in patients with idiopathic hypersomnia (IH). This proof-of-concept [...]

SAN JOSE, Calif: Kleine-Levin Syndrome Foundation has issued the following news release: The Kleine-Levin Syndrome Foundation today relaunched its Medical Advisory Board to help accelerate scientific understanding about KLS. The [...]

Members help encourage scientific inquiry; provide patients evidence-based information and guidance SAN JOSE, Calif., Jan. 30, 2024 /PRNewswire/ --The Kleine-Levin Syndrome Foundation today relaunched its Medical Advisory Board to help [...]

Global Community Unites to Illuminate the Challenges and Treatment Aspirations of People Living with Idiopathic Hypersomnia WEST PALM BEACH, Fla., Dec. 7, 2023 /PRNewswire/ -- The Sleep Consortium, in collaboration [...]

Patients with other conditions, such as coronary artery disease or cerebrovascular disease, should also be referred to a sleep center if OSA is suspected on the basis of comprehensive sleep assessment. However, it is crucial for primary care physicians to exercise caution in cases in which the clinical presentation is not straightforward or when OSA is associated with comorbidities. Obstructive sleep apnea (OSA) remains a significantly underdiagnosed condition, despite its high prevalence. [Extracted from the article]

CELEBRATION: Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, announced interim data from the open-label dose titration phase of the Phase 2 clinical trial [...]

Data generated to date indicate SDX is well-tolerated across all doses and both dosing regimens studied, laying the groundwork for future Phase 3 trial Topline data from completed trial expected [...]

Zevra is a corporate sponsor of the Hypersomnia Foundation and Beyond Sleepy Conference CELEBRATION, Fla., June 03, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company, [...]

CELEBRATION: KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare central nervous system (CNS) disorders, neurodegenerative diseases, lysosomal [...]

CELEBRATION, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare central [...]

CELEBRATION, Fla: KemPharm has issued the following news release: KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare [...]

Regular exercise is linked to better sleep, according to new research. The study included 4,339 adults aged 39-67 from nine countries, who were followed up over a 10-year period. The results showed that those who were consistently physically active were less likely to report difficulties with sleep initiation, short sleep duration, and long sleep duration. However, the study did not explore the influence of mental health or chronic pain on the relationship between exercise and sleep. [Extracted from the article]

2023 MAY 1 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

2022 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Nervous System Diseases and Conditions - Kleine-Levin Syndrome have been [...]

PLYMOUTH MEETING: Harmony Biosciences has issued the following news release: Harmony Biosciences Holdings, Inc. ('Harmony') (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with [...]

IND for pitolisant for treatment of idiopathic hypersomnia accepted Trial initiation anticipated first half of 2022 PLYMOUTH MEETING, Pa., Dec. 1, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ('Harmony') (Nasdaq: [...]

2022 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on Kleine-Levin syndrome have been published. According to news reporting [...]

M2 PHARMA-April 28, 2022-Harmony Biosciences starts pitolisant phase three trial assessing efficacy and safety in adult idiopathic hypersomnia patients (C)2022 M2 COMMUNICATIONS Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a US-based [...]

M2 EQUITYBITES-April 28, 2022-Harmony Biosciences starts pitolisant phase three trial assessing efficacy and safety in adult idiopathic hypersomnia patients (C)2022 M2 COMMUNICATIONS http://www.m2.com Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a [...]

Byline: DNA webdesk Deepika Padukone had previously joked that Ranveer Singh is a cat since he sleeps for 20 hours straight Deepika Padukone is back at pulling husband Ranveer Singh's [...]

2022 FEB 4 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Nervous System Diseases and Conditions - Kleine-Levin Syndrome. [...]

Xywav demonstrated statistically significant differences in change in Epworth Sleepiness Scale score (p-value The safety profile in this study was consistent with the known safety profile of Xywav with no [...]

DUBLIN: Jazz Pharmaceuticals plc has issued the following news release: Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation [...]

Final FDA decision anticipated by August 12 Phase 3 study results to be presented during AAN Annual Meeting Clinical Trials Plenary Session on April 20 Company to host investor webcast [...]

2021 NOV 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in Life Science Research - Biological Rhythms. According to [...]

2021 OCT 11 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

SWITZERLAND: NLS Pharmaceutics has issued the following press release: NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including narcolepsy, [...]

NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including narcolepsy, idiopathic hypersomnia and Kleine Levin Syndrome, and of neurodevelopmental [...]

STANS, Switzerland, Mar 02, 2020 (GLOBE NEWSWIRE via COMTEX) -- NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including [...]

Sydney, Australia: Medibio Limited has issued the following news release: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company pioneering the use of objective measures to [...]

The British woman who was convicted of lying about being gang raped by 12 Israeli men in Cyprus has PTSD, sleeps 20 hours a day and suffers hallucinations when she [...]

2020 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on transportation. According to news reporting out of Tehran, [...]

STANS, Switzerland: NLS Pharmaceutics has issued the following press release: NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including [...]

STANS, Switzerland, Sep 30, 2019 (GLOBE NEWSWIRE via COMTEX) -- NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including [...]

A decade ago, Emory neurologist and doctor Lynn Marie Trotti made an accidental discovery when one of her patients was prescribed the antibiotic clarithromycin for an infection. After taking the [...]

ATLANTA, Georgia -- The following information was released by Emory University: The National Institute of Neurological Disorders and Stroke has awarded a five-year $2.1 million grant to Emory neurologist Lynn [...]

Switzerland: NLS Pharmaceutics has issued the following news release: NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including narcolepsy, [...]

STANS, Switzerland, Aug 13, 2019 (GLOBE NEWSWIRE via COMTEX) -- NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments of rare neurological diseases including [...]

Switzerland: NLS Pharmaceutics has issued the following press release: NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments for the Central Nervous System (CNS) [...]

STANS, Switzerland, Jul 03, 2019 (GLOBE NEWSWIRE via COMTEX) -- NLS Pharmaceutics Ltd. (NLS), a Swiss biotech firm focusing on the development of novel treatments for the Central Nervous System [...]

ATLANTA -- The HYPERSOMNIA FOUNDATION , a leading nonprofit patient advocacy group dedicated to improving the lives of people with idiopathic hypersomnia and other rare sleep disorders, is pleased to [...]

DUBLIN -- The 'Hypersomnia - Pipeline Insight, 2019' drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth [...]

M2 PRESSWIRE-April 1, 2019-: Hypersomnia - Pipeline Insight Study, 2019 (C)1994-2019 M2 COMMUNICATIONS RDATE:01042019 The 'Hypersomnia - Pipeline Insight, 2019' drug pipelines has been added to ResearchAndMarkets.com's offering. The report [...]

A 21-year-old U.K. student suffers from a rare neurological disorder which sometimes causes her to sleep for three weeks at a stretch. Rhoda Rodriguez-Diaz was diagnosed with Kleine-Levin syndrome, also [...]